We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBX
976
DELISTED
Unity Biotechnology
UBX
$6K ﹤0.01%
122
+78
+177% +$3.76K
VYGR icon
977
Voyager Therapeutics
VYGR
$201M
$6K ﹤0.01%
860
+540
+169% +$5.19K
YARW
978
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$6K ﹤0.01%
+1
New +$6.28K
ORTX
979
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$6K ﹤0.01%
140
+89
+175% +$3.99K
RVLP
980
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$6K ﹤0.01%
1,475
+931
+171% +$5.37K
PRTK
981
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$6K ﹤0.01%
+1,050
New +$6.18K
JNCE
982
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$6K ﹤0.01%
+945
New +$7.36K
CHMA
983
DELISTED
Chiasma, Inc. Common Stock
CHMA
$6K ﹤0.01%
1,385
+893
+182% +$3.72K
AWR icon
984
American States Water
AWR
$3.46B
$5K ﹤0.01%
75
+41
+121% +$3.14K
ENR icon
985
Energizer
ENR
$1.55B
$5K ﹤0.01%
141
+39
+38% +$1.65K
KZR
986
DELISTED
Kezar Life Sciences
KZR
$5K ﹤0.01%
+113
New +$6.29K
MNOV icon
987
MediciNova
MNOV
$66M
$5K ﹤0.01%
+1,030
New +$5.9K
XERS icon
988
Xeris Biopharma Holdings
XERS
$1.45B
$5K ﹤0.01%
1,155
+761
+193% +$3.81K
ASMB icon
989
Assembly Biosciences
ASMB
$529M
$4K ﹤0.01%
63
+40
+174% +$4.69K
META icon
990
Meta Platforms (Facebook)
META
$1.51T
$3K ﹤0.01%
12
-4,777
-100% -$1.31M
OVID icon
991
Ovid Therapeutics
OVID
$491M
$3K ﹤0.01%
+1,455
New +$6.78K
ELVT
992
DELISTED
Elevate Credit, Inc.
ELVT
$3K ﹤0.01%
830
+827
+27,567% +$2.43K
APRE icon
993
Aprea Therapeutics
APRE
$8.05M
$2K ﹤0.01%
+24
New +$11.4K
CNF
994
CNFinance Holdings
CNF
$37.3M
$1K ﹤0.01%
47
-1
-2% -$34
DNB
995
DELISTED
Dun & Bradstreet
DNB
$1K ﹤0.01%
+70
New +$1.87K
OMF icon
996
OneMain Financial
OMF
$7.47B
$1K ﹤0.01%
22
+7
+47% +$276
HTT
997
High Templar Tech Ltd
HTT
$391M
$1K ﹤0.01%
937
-287,896
-100% -$393K
SOS
998
SOS Limited
SOS
$14.6M
$1K ﹤0.01%
2
+1
+100% +$1.52K
XYF
999
X Financial
XYF
$204M
$1K ﹤0.01%
865
+278
+47% +$603
JT
1000
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
$1K ﹤0.01%
489
-702
-59% -$2.49K
38 39
40
41 42

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.